Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · IEX Real-Time Price · USD
6.35
+0.13 (2.09%)
At close: Jul 19, 2024, 12:00 AM
6.33
-0.02 (-0.31%)
Pre-market: Jul 22, 2024, 8:50 AM EDT
Titan Pharmaceuticals Employees
Titan Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$21,750
Profits / Employee
-$1,238,500
Market Cap
5.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PolyPid | 62 |
Biomerica | 62 |
Ainos | 46 |
Hepion Pharmaceuticals | 22 |
TFF Pharmaceuticals | 19 |
Soligenix | 15 |
Aethlon Medical | 14 |
Sonoma Pharmaceuticals | 10 |
TTNP News
- 6 months ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 7 months ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 9 months ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 11 months ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Provides Shareholder Update - GlobeNewsWire
- 1 year ago - UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. - GlobeNewsWire
- 2 years ago - Titan Pharmaceuticals Announces Board Expansion and Management Changes - PRNewsWire